MYGN MYRIAD GENETICS INC
2026Q1 · CUSIP 62855J104 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
202
Δ holders QoQ
-19
Breadth percentile
Top 92%
Whale holders
116
Δ whales
-5
Inst. holding value
$517M
New positions
33
Closed positions
52
Price momentum (1Q)
-18.9%
Put / Call
1/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q3 | Top 15% | -6.8% | -74.2% |
| 2024Q2 | Top 5% | -44.4% | -47.1% |
| 2018Q3 | Top 6% | +0.9% | -21.0% |
| 2018Q1 | Top 19% | +20.1% | -15.5% |
Options Sentiment
Put holders
1
QoQ: +1
Call holders
1
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-4.31
EPS YoY
—
Revenue (TTM)
$0.8B
Revenue YoY
-0.3%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)